Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Thomas P. Potjer"'
Autor:
Monique A. M. de Jong, Eleonora P. M. Corssmit, Jeroen C. Jansen, Thomas P. Potjer, Jean-Pierre L. Bayley, Erik F. Hensen
Publikováno v:
Case Reports in Otolaryngology, Vol 2024 (2024)
Head and neck paragangliomas are slow growing and highly vascular neuroendocrine tumors. It is currently assumed that SDHAF2 variants exclusively cause benign and often multicentric head and neck paragangliomas. Here, we present a patient diagnosed w
Externí odkaz:
https://doaj.org/article/c340520502634510a385d32b1333df7f
Autor:
Thomas P. Potjer, Bart J. Mertens, Simone Nicolardi, Yuri E. M van der Burgt, Bert. A. Bonsing, Wilma E. Mesker, Rob A. E. M Tollenaar, Hans F. A Vasen
Publikováno v:
Translational Oncology, Vol 9, Iss 3, Pp 242-247 (2016)
BACKGROUND: Pancreatic cancer (PC) surveillance is currently offered to individuals with a genetic predisposition to PC, but routinely used radiological screening modalities are not entirely reliable in detecting early-stage PC or its precursor lesio
Externí odkaz:
https://doaj.org/article/50a6b2409fe64e5b951ded04ff02cb32
Autor:
Derk C.F. Klatte, Bas Boekestijn, Martin N.J.M. Wasser, Shirin Feshtali Shahbazi, Isaura S. Ibrahim, J. Sven D. Mieog, Saskia A.C. Luelmo, Hans Morreau, Thomas P. Potjer, Akin Inderson, Jurjen J. Boonstra, Friedo W. Dekker, Hans F.A. Vasen, Jeanin E. van Hooft, Bert A. Bonsing, Monique E. van Leerdam
Publikováno v:
Journal of Clinical Oncology, 40(28), 3267-+. LIPPINCOTT WILLIAMS & WILKINS
Journal of clinical oncology, 4:JCO.22.00194. American Society of Clinical Oncology
Journal of clinical oncology, 4:JCO.22.00194. American Society of Clinical Oncology
PURPOSE Pancreatic cancer surveillance in high-risk individuals may lead to detection of pancreatic ductal adenocarcinoma (PDAC) at an earlier stage and with improved survival. This study evaluated the yield and outcomes of 20 years of prospective su
Autor:
Derk C.F. Klatte, Bas Boekestijn, Anke M. Onnekink, Friedo W. Dekker, Lydia G. van der Geest, Martin N.J.M. Wasser, Shirin Feshtali, J. Sven D. Mieog, Saskia A.C. Luelmo, Hans Morreau, Thomas P. Potjer, Akin Inderson, Jurjen J. Boonstra, Hans F.A. Vasen, Jeanin E. van Hooft, Bert A. Bonsing, Monique E. van Leerdam
Publikováno v:
Gastroenterology. 164:1223-1231.e4
Autor:
Derk C.F. Klatte, Heather D. Hardway, Jason S. Starr, Douglas L. Riegert-Johnson, Kristin E. Clift, Thomas P. Potjer, Monique E. van Leerdam, R. John Presutti, Michael B. Wallace, Yan Bi
Publikováno v:
Journal of Clinical Oncology. 41:688-688
688 Background: Guidelines recommend patients with pancreatic ductal adenocarcinoma (PDAC) undergo genetic testing for germline pathogenic variants (PV). The aim of this study was to evaluate compliance with recently updated guidelines (May 2019) and
Autor:
Derk C.F. Klatte, Bas Boekestijn, Anke M. Onnekink, Friedo W. Dekker, Lydia G. van der Geest, Martin N.J.M.M. Wasser, Shirin Feshtali, J. Sven D. Mieog, Hans Morreau, Thomas P. Potjer, Akin Inderson, Jurjen J. Boonstra, Hans F.A. Vasen, Saskia Luelmo, Jeanin E. van Hooft, Bert A. Bonsing, Monique E. van Leerdam
Publikováno v:
Journal of Clinical Oncology. 41:690-690
690 Background: Recent pancreatic cancer surveillance programs of high-risk individuals have reported improved outcomes. This study assessed to what extent outcomes of pancreatic ductal adenocarcinoma (PDAC) in patients with a CDKN2A/p16 pathogenic v
Autor:
Lambertus A. Kiemeney, Inge M. M. Lakeman, Mar Rodríguez-Girondo, Tara W J van der Grinten, Jennifer H. Barrett, Thomas P. Potjer, Mark M. Iles, Christi J. van Asperen, Nienke van der Stoep, Nelleke A. Gruis, Sander Bollen
Publikováno v:
Journal of Medical Genetics, 58(11), 760-766. BMJ PUBLISHING GROUP
Journal of Medical Genetics
Journal of Medical Genetics, 58, 760-766
Journal of Medical Genetics, 2021(58), 760-766. BMJ Publishing Group
Journal of Medical Genetics, 58, 11, pp. 760-766
Journal of Medical Genetics
Journal of Medical Genetics, 58, 760-766
Journal of Medical Genetics, 2021(58), 760-766. BMJ Publishing Group
Journal of Medical Genetics, 58, 11, pp. 760-766
BackgroundFamilial clustering of melanoma suggests a shared genetic predisposition among family members, but only 10%–40% of familial cases carry a pathogenic variant in a known high-risk melanoma susceptibility gene. We investigated whether a mela
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7ab7607027d0f8c06f5ea07758f8d20
https://jmg.bmj.com/content/jmedgenet/early/2020/09/28/jmedgenet-2020-107251.full.pdf
https://jmg.bmj.com/content/jmedgenet/early/2020/09/28/jmedgenet-2020-107251.full.pdf
Autor:
Thomas P. Potjer
Publikováno v:
Gut. BMJ PUBLISHING GROUP
Gut
Gut
Individuals at high risk for pancreatic cancer (PC) could potentially benefit from regular surveillance, as the first clinical symptoms of PC often appear only at an advanced stage, at which point the prognosis is often dismal. PC surveillance is the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3838b0ac0c1a3ab4bd4f2bd510cc3a65
https://hdl.handle.net/1887/3270975
https://hdl.handle.net/1887/3270975
Autor:
Regina Bökenkamp-Gramann, Daniela Q.C.M. Barge-Schaapveld, Monique Williams, Julie W. Rutten, Karin van der Tuin, Esther A. R. Nibbeling, Claudia A. L. Ruivenkamp, Sylke J. Steggerda, Laura Donker Kaat, Dietje E. Fransen van de Putte, Remco van Doorn, Marjolein Kriek, Ruben S G M Witlox, Maartje van Rij, Cacha M.P.C.D. Peeters-Scholte, Arie van Haeringen, Thomas P. Potjer, Emilia K. Bijlsma, Setareh Moghadasi, Yvette van Ierland, Manon Suerink, Emmelien Aten, Gijs W. E. Santen, Remco Visser, Anne Sophie van der Werf–t Lam, Mariëtte J.V. Hoffer, Marije Koopmans, Pleuntje J. van der Sluijs, Ratna N G B Tan, Nicolette S. den Hollander, Arend D. J. ten Harkel, Yvonne Hilhorst-Hofstee
Publikováno v:
Genetics in Medicine. 21:2159-2164
The original version of this Article contained an error in the spelling of the author Pleuntje J. van der Sluijs, which was incorrectly given as Eline (P. J.) van der Sluijs. This has now been corrected in both the PDF and HTML versions of the Articl
Autor:
Setareh Moghadasi, Emilia K. Bijlsma, Remco van Doorn, Monique Williams, Maartje van Rij, Remco Visser, Thomas P. Potjer, Arend D. J. ten Harkel, Yvette van Ierland, Laura Donker Kaat, Emmelien Aten, Daniela Q.C.M. Barge-Schaapveld, Cacha M.P.C.D. Peeters-Scholte, Nicolette S. den Hollander, Ratna N G B Tan, Ruben S G M Witlox, Regina Bökenkamp-Gramann, Julie W. Rutten, Manon Suerink, Marjolein Kriek, Yvonne Hilhorst-Hofstee, Sylke J. Steggerda, Mariëtte J.V. Hoffer, Marije Koopmans, Pleuntje J. van der Sluijs, Anne-Sophie van der Werf –’t Lam, Gijs W. E. Santen, Claudia A. L. Ruivenkamp, Dietje E. Fransen van de Putte, Arie van Haeringen, Karin van der Tuin, Esther A. R. Nibbeling
Publikováno v:
Genetics in Medicine, 21(5), 1074-1082. Lippincott Williams & Wilkins
Genetics in Medicine, 21(5), 1074-1082
Genetics in Medicine
Genetics in medicine, 21(5), 1074-1082. Lippincott Williams and Wilkins
Genetics in Medicine, 21(5), 1074-1082
Genetics in Medicine
Genetics in medicine, 21(5), 1074-1082. Lippincott Williams and Wilkins
Purpose: Several studies have reported diagnostic yields up to 57% for rapid exome or genome sequencing (rES/GS) as a single test in neonatal intensive care unit (NICU) patients, but the additional yield of rES/GS compared with other available diagno